Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Mark Ainsworth(John Brown University), Christopher J. Groves, Marc Emmenegger(University of Zurich), Matthew Catton, Shayan Fassih, Monique Andersson(John Radcliffe Hospital), Julie Dequaire, Rory Fairhead(Queen's Hospital), Sally Beer, Kathryn Auckland, Tim Brooks, Kate E. Dingle, Eleanor Barnes(Oxford Health NHS Foundation Trust), J. Kenneth Baillie(NHS Lothian), Elizabeth Clutterbuck(University of Oxford), Abbie Bown, Thomas Christott, Silvia D’Arcangelo, Verónica Sánchez, Sally Felle, Christina Dold(University of Oxford), John Frater(University of Oxford), Conor Feehily, Martyna Borak, Kevin Chau, David W. Eyre(Health Protection Scotland), Sagida Bibi(University of Oxford), Nick Gent, Alejandra Fernandez‐Cid, N. Burgess-Brown, Richard J. Cornall(John Radcliffe Hospital), Tao Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Amy Beveridge, Susanna Dunachie(Mahidol University), Jesse A. Coker, David Crawford-Jones, Thomas Fordwoh, Derrick W. Crook(John Radcliffe Hospital), Dominique Georgiou, Daniel Ebner, Wanwisa Dejnirattsai, Stavros Dimitriadis, Thomas Foord, George Doherty, Maria Fernandez Mendoza, Luke Blackwell, Susana Camara, Deborah McKee, Stuart Cox, Alexis Espinosa
Cited by 405
Related Papers
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k